News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
763,781 Results
Type
Article (53293)
Company Profile (312)
Press Release (710165)
Multimedia
Podcasts (125)
Webinars (22)
Section
Business (209823)
Career Advice (2067)
Deals (36292)
Drug Delivery (145)
Drug Development (85155)
Employer Resources (174)
FDA (17020)
Job Trends (15307)
News (356625)
Policy (33776)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (3)
2027 Genetown Standard (3)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2785)
Academic (1)
Accelerated approval (58)
ADA (45)
Adcomms (37)
Allergies (195)
Alliances (51412)
ALS (232)
Alzheimer's disease (1862)
Antibody-drug conjugate (ADC) (575)
Approvals (17468)
Artificial intelligence (765)
ASCO (343)
Autoimmune disease (353)
Automation (63)
Bankruptcy (373)
Best Places to Work (11859)
BIO (71)
BIOSECURE Act (22)
Biosimilars (238)
Biotechnology (216)
Bladder cancer (214)
Brain cancer (84)
Breast cancer (858)
Cancer (6732)
Cardiovascular disease (517)
Career advice (1759)
Career pathing (45)
CAR-T (379)
CDC (61)
Celiac Disease (3)
Cell therapy (1017)
Cervical cancer (58)
Clinical research (74251)
Collaboration (2307)
Commercialization (1)
Company closure (7)
Compensation (1542)
Complete response letters (96)
COVID-19 (2812)
CRISPR (125)
C-suite (1292)
Cystic fibrosis (161)
Data (8809)
Decentralized trials (3)
Denatured (35)
Depression (177)
Dermatology (99)
Diabetes (673)
Diagnostics (7334)
Digital health (67)
Diversity (13)
Diversity, equity & inclusion (46)
Drug discovery (382)
Drug pricing (213)
Drug shortages (31)
Duchenne muscular dystrophy (314)
Earnings (93381)
Editorial (72)
Employer branding (21)
Employer resources (156)
Events (124513)
Executive appointments (1164)
FDA (21129)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (22)
Frontotemporal dementia (36)
Funding (1908)
Gene editing (266)
Generative AI (66)
Gene therapy (797)
GLP-1 (1120)
Government (4887)
Grass and pollen (7)
Guidances (421)
Healthcare (19680)
Hematology (197)
HIV (95)
Huntington's disease (65)
IgA nephropathy (113)
Immunology and inflammation (317)
Immuno-oncology (119)
Indications (223)
Infectious disease (3184)
Inflammatory bowel disease (233)
Inflation Reduction Act (15)
Influenza (144)
Intellectual property (323)
Interviews (326)
IPO (16956)
IRA (51)
Job creations (3752)
Job search strategy (1458)
JPM (64)
Kidney cancer (23)
Labor market (112)
Layoffs (616)
Leadership (42)
Legal (8193)
Liver cancer (111)
Longevity (35)
Lung cancer (891)
Lymphoma (484)
Machine learning (66)
Management (61)
Manufacturing (1181)
Marketing (4)
MASH (215)
Medical affairs (1)
Medical device (14119)
Medtech (14295)
Mergers & acquisitions (20652)
Metabolic disorders (1679)
mRNA (257)
Multiple sclerosis (201)
NASH (17)
Neurodegenerative disease (470)
Neuropsychiatric disorders (113)
Neuroscience (3529)
Neurotech (1)
NextGen: Class of 2026 (6760)
Non-profit (4722)
Now hiring (83)
Obesity (773)
Opinion (319)
Ovarian cancer (251)
Pain (272)
Pancreatic cancer (374)
Parkinson's disease (401)
Partnered (36)
Patents (656)
Patient recruitment (793)
Peanut (67)
People (61417)
Pharmaceutical (61)
Pharmacy benefit managers (33)
Phase 1 (23258)
Phase 2 (32580)
Phase 3 (24286)
Pipeline (10048)
Policy (346)
Postmarket research (2820)
Preclinical (10057)
Press Release (67)
Prostate cancer (355)
Psychedelics (61)
Radiopharmaceuticals (369)
Rare diseases (1248)
Real estate (6136)
Recruiting (71)
Regulatory (26695)
Reports (56)
Research institute (2599)
Resumes & cover letters (357)
Rett syndrome (46)
RNA editing (28)
RSV (91)
Schizophrenia (185)
Series A (323)
Series B (241)
Service/supplier (12)
Sickle cell disease (130)
Special edition (28)
Spinal muscular atrophy (180)
Sponsored (50)
Startups (3824)
State (2)
Stomach cancer (21)
Supply chain (135)
Tariffs (90)
The Weekly (87)
Vaccines (1203)
Venture capital (126)
Weight loss (498)
Women's health (138)
Worklife (21)
Date
Today (64)
Last 7 days (438)
Last 30 days (2110)
Last 365 days (31095)
2026 (16841)
2025 (30917)
2024 (36057)
2023 (40956)
2022 (52221)
2021 (56778)
2020 (55085)
2019 (47717)
2018 (35968)
2017 (33329)
2016 (32834)
2015 (38837)
2014 (32633)
2013 (28046)
2012 (30314)
2011 (30854)
2010 (29172)
Location
Africa (793)
Alabama (93)
Alaska (7)
Arizona (374)
Arkansas (14)
Asia (42380)
Australia (7129)
California (14247)
Canada (4013)
China (1554)
Colorado (605)
Connecticut (624)
Delaware (436)
Europe (94195)
Florida (2134)
Georgia (451)
Hawaii (3)
Idaho (64)
Illinois (1175)
India (100)
Indiana (637)
Iowa (26)
Japan (608)
Kansas (137)
Kentucky (52)
Louisiana (58)
Maine (76)
Maryland (1704)
Massachusetts (10257)
Michigan (379)
Minnesota (771)
Mississippi (6)
Missouri (152)
Montana (36)
Nebraska (30)
Nevada (150)
New Hampshire (85)
New Jersey (3728)
New Mexico (32)
New York (3752)
North Carolina (1804)
North Dakota (10)
Northern California (7185)
Ohio (426)
Oklahoma (23)
Oregon (45)
Pennsylvania (2828)
Puerto Rico (31)
Rhode Island (53)
South America (1167)
South Carolina (89)
South Dakota (2)
Southern California (5640)
Tennessee (233)
Texas (2287)
United States (50324)
Utah (424)
Vermont (2)
Virginia (345)
Washington D.C. (81)
Washington State (1157)
West Virginia (4)
Wisconsin (148)
Wyoming (2)
763,781 Results for "cancer genetics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Labcorp Supports Multi-Institution Trial to Expand Genetic Testing in Colorectal Cancer
May 29, 2026
·
3 min read
Press Releases
Myriad Genetics Expands Availability of Precise MRD™ for Colorectal, Renal and Breast Cancers, Supported by New Publication
June 23, 2026
·
6 min read
Press Releases
Synnovis and SOPHiA GENETICS Partner to Bring Blood-based Cancer Testing to Patients Across the U.K.
May 13, 2026
·
6 min read
Press Releases
Myriad Genetics Expands Access for MyChoice Test to Prostate Cancer Patients in Japan
April 14, 2026
·
3 min read
Press Releases
Myriad Genetics Launches Prolaris® + AI, the First Prostate Cancer Test to Combine Genomics and Digital Pathology Artificial Intelligence (AI)
May 26, 2026
·
6 min read
Press Releases
92Bio, Inc. Doses First Patient in Phase 1 Clinical Trial of NTB-928 in Platinum-Resistant Ovarian Cancer
July 1, 2026
·
3 min read
Press Releases
Nivi, Inc. and MSD Collaborate to Expand HPV Disease Awareness and Cervical Cancer Prevention Through AI-Powered Platform
June 16, 2026
·
4 min read
Press Releases
Myriad Genetics Underscores Commitment to Cancer Care Continuum with New Data Presentations at SGO Annual Meeting
April 10, 2026
·
4 min read
HIV
Merck, Gilead serve ‘sweet and sour’ spread after HIV win, cancer stumble
While Merck and Gilead Sciences reported back-to-back late-stage victories for their weekly HIV pill, the partners also discontinued a Phase 3 program for their cancer combo after disappointing lung cancer survival data.
June 9, 2026
·
2 min read
·
Tristan Manalac
Pancreatic cancer
Can Revolution’s ‘miracle’ pancreatic cancer drug be topped? Immuneering, Actuate say yes
Last month, Revolution Medicines’ RAS inhibitor doubled survival in a Phase 3 pancreatic cancer trial. On the biotech’s heels are Immuneering, Actuate Therapeutics, Erasca and more, looking to improve on that result with increased tolerability—and more time for patients.
May 18, 2026
·
7 min read
·
Heather McKenzie
1 of 76,379
Next
